The “game changer” statement above comes from an independent review of the potential value of gallium-86-labeled prostate-specific molecular antigen (68Ga PSMA) PET scanning in the evaluation of selected men with prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: Diagnosis, gallium-68, PET, prognosis, PSMA, scan, work-up | 4 Comments »
A newly published article in Reviews in Urology argues that, on economic grounds alone, the majority of patients thought to be at risk for prostate cancer should have a 4KScore test prior to them being given a biopsy since this test can rule out the need for biopsies with a high degree of accuracy. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, Diagnosis, risk, test, work-up | 7 Comments »
Whatever one may happen to think about the value of the PSA test, we all know that it is very bad at actually telling a doctor or a patient if that patient is at real risk for clinically significant prostate cancer. So, from that perspective … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, evaluation, MRI, PSA, research, risk, work-up | 2 Comments »
According to information from the Medical University of Vienna (in Austria) and Vienna General Hospital, researchers at these centers have been developing what they believe to be a smarter set of strategies for assessing prostate cancer risk and subsequent treatment, when this is needed. … READ MORE …
Filed under: Diagnosis, Management, Risk, Uncategorized | Tagged: Diagnosis, prognosis, risk, Treatment, work-up | Leave a comment »
Support group leaders and other prostate cancer educators may wish to test their knowledge on the diagnosis and staging of prostate cancer by reading through the set of 29 slides prepared by Kleynberg and Gross and just made available on the Medscape web site.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, grade, stage, work-up | 2 Comments »
For any man with a first-time PSA level > 10 ng/ml, there is significant risk for prostate cancer, and early follow-up care — including a repeat PSA test and potentially a biopsy — is probably a priority unless the patient has a life expectancy of 10 years or less. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: care, delay, Diagnosis, follow-up, work-up | Leave a comment »
Every year tens of thousands of men newly diagnosed with prostate cancer are given a bone scan (and other types of scan) as part of their “normal” diagnostic work-up. The only value of the bone scan is that it is able to identify men who already have (or at least may have evidence suggesting) actual metastatic prostate cancer to their bones at the time of diagnosis. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: bone scan, Diagnosis, guideline, work-up | 6 Comments »
On May 11 we noted a report on the potential value of MRI scans in clinical decision-making for prostate cancer patients prior to surgery. Today there is a new report on the potential of positron emission tomography (PET) compared to MRI in a similar (but not precisely the same) situation. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: MRI, PET, positrom emission spectroscopy, work-up | Leave a comment »
In today’s new reports we summarize information from recent papers dealing with:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: apex, biochemical recurrence, biopsy, Diagnosis, dissection, imaging, intrafascial, open, RALP, risk, robot-assisted, surgery, work-up | 1 Comment »
A new review just published in BJU International provides a current expert perspective on the roles of PSA and the much newer PCA3 test in the work-up and diagnosis of a patient suspected of prostate cancer. The entire article is available on line and will be a useful resource for many support group leaders and other prostate cancer educators. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: Diagnosis, PCA3, PSA, work-up | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 